According to the local testing criteria in use, 73.2% of patients included in this study underwent genetic testing, and 30% of them presented germline likely pathogenic or pathogenic variants in cancer predisposition genes (24 BRCA1, 4 BRCA2, 1 PALB2, 1 NBN, and 1 ATM). The gene discussed is BRCA1; the disease is cancer.